Professor Paul Marik, MD - Prevention & Early Treatment of COVID-19: a Webinar - Q&As

blueheelercd | 15 points | Dec 15 2020 03:13:47

Professor Paul Marik, MD - Prevention & Early Treatment of COVID-19: a Webinar - Q&As - FLCCC

When: Thursday December 17 at 11 AM EDT Format: 15 minutes presentation and 45 minutes for Q&As Audience: Medical professionals seeking education about prevention and early treatment of C19, as well as anyone seeking information about this extremely important matter. Where: Online.

REGISTRATION: FREE – RSVP REQUIRED- link below.

Today, there is a crisis in hospitals in the US and many other countries, where C19 is not treated before hospitalization. Yet a key to resolve the crisis is the prevention and early treatment of the disease, at home, or even in nursing homes. With prevention and early treatment, the odds of hospitalization are substantially reduced.

On April 24, Professor Paul Marik and his team released a first “MATH+” treatment protocol, covering the various stages of the C19 disease. Early treatment protocols have evolved. This webinar will provide an update about the treatment protocols recommended by Paul Marik, and the Front Line COVID-19 Critical Care Working Group. FLCCC. Emphasis on the I-Mask+ Protocol, focuses on the prevention and early treatment of C19. https://covexit.com/prevention-early-treatment-of-covid-19-a-webinar-with-professor-paul-marik-md/

[-] TrumpLyftAlles | 1 points | Dec 15 2020 06:48:41

How often do you get a chance to ask Dr. Marik a question?

Well, I've asked him several -- but he never replies to my emails. No wonder: his autoresponder says he gets 400/day.

As we used to say in my high school nerd club:

Be present or be dodecahedrant!

(Does anyone get this "joke"?)

[-] blueheelercd | 2 points | Dec 15 2020 07:05:56

45 minute Q & A. You can ask questions in your rsvp too. I sent him the new paper in Nature, that someone posted about today, with a YouTube. Possible adjunct monoclonal antibody that stops the blood clumping by Covid. Incredible paper. Will work with IVM. Did you see it? No, do not get joke! I would love to hear your questions!

[-] Haitchpeasauce | 1 points | Dec 15 2020 08:24:42

Can you please link the paper here?

[-] blueheelercd | 2 points | Dec 16 2020 03:32:12

https://www.nature.com/articles/s41392-020-00426-x

Response from FLCCC:

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3636557 IVM shields SARS-CoV-2 spike protein and that this spike protein binds to the CD147 transmembrane receptor as well as to ACE2

[-] Ok-Film-9049 | 2 points | Dec 15 2020 08:01:29

Is it a play on the expression, be there or be square?

[-] TrumpLyftAlles | 2 points | Dec 15 2020 16:26:44

You got it! :)